Bionic Sight’s BS01 gene therapy receives RMAT designation from the FDA April 7, 2025 Categories: Health Care Tags: Bionic Sight
Bionic Sight’s BS01 gene therapy receives RMAT designation from the FDA February 24, 2025 Categories: Health Care Tags: Bionic Sight
Bionic Sight, LLC Doses First Patient in a Phase 1/2 Clinical Trial of a New Investigational Treatment for Blindness caused by Retinitis Pigmentosa June 16, 2020 Categories: Uncategorized Tags: Bionic Sight
